BMRN
Price
$67.92
Change
-$2.77 (-3.92%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
13.49B
21 days until earnings call
SRPT
Price
$61.86
Change
-$1.96 (-3.07%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
6.19B
28 days until earnings call
Ad is loading...

BMRN vs SRPT

Header iconBMRN vs SRPT Comparison
Open Charts BMRN vs SRPTBanner chart's image
BioMarin Pharmaceutical
Price$67.92
Change-$2.77 (-3.92%)
Volume$17.79K
Capitalization13.49B
Sarepta Therapeutics
Price$61.86
Change-$1.96 (-3.07%)
Volume$101.22K
Capitalization6.19B
BMRN vs SRPT Comparison Chart
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. SRPT commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Buy and SRPT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (BMRN: $70.69 vs. SRPT: $63.82)
Brand notoriety: BMRN: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 113% vs. SRPT: 300%
Market capitalization -- BMRN: $13.49B vs. SRPT: $6.19B
BMRN [@Biotechnology] is valued at $13.49B. SRPT’s [@Biotechnology] market capitalization is $6.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, SRPT is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 2 TA indicator(s) are bullish while SRPT’s TA Score has 4 bullish TA indicator(s).

  • BMRN’s TA Score: 2 bullish, 6 bearish.
  • SRPT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SRPT is a better buy in the short-term than BMRN.

Price Growth

BMRN (@Biotechnology) experienced а -1.81% price change this week, while SRPT (@Biotechnology) price change was -16.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

BMRN is expected to report earnings on Apr 23, 2025.

SRPT is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($13.5B) has a higher market cap than SRPT($6.19B). BMRN has higher P/E ratio than SRPT: BMRN (31.99) vs SRPT (26.46). BMRN YTD gains are higher at: 7.546 vs. SRPT (-47.512). BMRN has higher annual earnings (EBITDA): 651M vs. SRPT (317M). SRPT has more cash in the bank: 1.36B vs. BMRN (1.14B). BMRN has less debt than SRPT: BMRN (603M) vs SRPT (1.34B). BMRN has higher revenues than SRPT: BMRN (2.85B) vs SRPT (1.9B).
BMRNSRPTBMRN / SRPT
Capitalization13.5B6.19B218%
EBITDA651M317M205%
Gain YTD7.546-47.512-16%
P/E Ratio31.9926.46121%
Revenue2.85B1.9B150%
Total Cash1.14B1.36B84%
Total Debt603M1.34B45%
FUNDAMENTALS RATINGS
BMRN vs SRPT: Fundamental Ratings
BMRN
SRPT
OUTLOOK RATING
1..100
6062
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7646
PRICE GROWTH RATING
1..100
5294
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRPT's Valuation (71) in the Biotechnology industry is in the same range as BMRN (72). This means that SRPT’s stock grew similarly to BMRN’s over the last 12 months.

SRPT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BMRN (100). This means that SRPT’s stock grew similarly to BMRN’s over the last 12 months.

SRPT's SMR Rating (46) in the Biotechnology industry is in the same range as BMRN (76). This means that SRPT’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's Price Growth Rating (52) in the Biotechnology industry is somewhat better than the same rating for SRPT (94). This means that BMRN’s stock grew somewhat faster than SRPT’s over the last 12 months.

BMRN's P/E Growth Rating (97) in the Biotechnology industry is in the same range as SRPT (100). This means that BMRN’s stock grew similarly to SRPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNSRPT
RSI
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 20 days ago
62%
Bullish Trend 9 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
69%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
66%
View a ticker or compare two or three
Ad is loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HNDL21.090.10
+0.48%
Strategy Shares Nasdaq 7 Handl™ ETF
JUNT31.570.13
+0.41%
AllianzIM U.S. Large Cp Buffer10 Jun ETF
IVVB29.320.05
+0.17%
iShares Large Cap Deep Buffer ETF
LMBS49.160.01
+0.02%
First Trust Low Duration Oppos ETF
EEMX33.59-0.12
-0.36%
SPDR® MSCI Em Mkts Fssl Ful Free RsrvETF

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with IBO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then IBO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-1.05%
IBO - BMRN
55%
Loosely correlated
-42.76%
SRPT - BMRN
45%
Loosely correlated
-9.36%
AXON - BMRN
42%
Loosely correlated
-1.68%
FGEN - BMRN
41%
Loosely correlated
-1.24%
ITOS - BMRN
40%
Loosely correlated
-5.54%
More